Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | March 06, 2023 09:06am

Gainers

  • Unicycive Therapeutics (NASDAQ:UNCY) shares increased by 114.3% to $1.05 during Monday's pre-market session. The company's market cap stands at $15.8 million.
  • BridgeBio Pharma (NASDAQ:BBIO) stock moved upwards by 56.39% to $17.0. The market value of their outstanding shares is at $2.5 billion.
  • vTv Therapeutics (NASDAQ:VTVT) stock increased by 48.51% to $1.2. The company's market cap stands at $97.7 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) shares increased by 27.46% to $21.35. The company's market cap stands at $39.9 million. The company's, Q4 earnings came out yesterday.
  • TCR2 Therapeutics (NASDAQ:TCRR) shares rose 25.61% to $1.52. The market value of their outstanding shares is at $58.7 million.
  • Armata Pharmaceuticals (AMEX:ARMP) shares increased by 16.66% to $3.22. The market value of their outstanding shares is at $116.3 million.

Losers

  • Aclaris Therapeutics (NASDAQ:ACRS) shares decreased by 36.5% to $8.11 during Monday's pre-market session. The company's market cap stands at $540.8 million.
  • Esperion Therapeutics (NASDAQ:ESPR) stock decreased by 33.76% to $4.2. The market value of their outstanding shares is at $321.6 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock decreased by 26.14% to $1.3. The company's market cap stands at $212.9 million. The company's, Q4 earnings came out today.
  • Rubius Therapeutics (NASDAQ:RUBY) shares declined by 19.94% to $0.1. The company's market cap stands at $9.0 million.
  • Sesen Bio (NASDAQ:SESN) shares declined by 13.25% to $0.54. The company's market cap stands at $108.4 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Etao International Co (NASDAQ:ETAO) stock fell 12.84% to $1.97. The company's market cap stands at $208.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRS ADAP ARMP BBIO ESPR ETAO KALA RUBY SESN TCRR UNCY VTVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist